Recommended Hibiclens Frequency for Staph Decolonization
For staphylococcal decolonization, use chlorhexidine (Hibiclens) daily for 5-14 days in combination with twice-daily intranasal mupirocin for 5-10 days, or alternatively, use dilute bleach baths twice weekly for 3 months. 1
Decolonization Regimen Options
The IDSA guidelines provide two evidence-based approaches for staph decolonization 1:
Option 1: Short-Course Intensive Regimen
- Chlorhexidine body wash: Daily application for 5-14 days
- Intranasal mupirocin 2%: Twice daily for 5-10 days
- Timing: Complete the regimen as close to any planned procedure as possible (1-2 weeks before surgery if applicable) 2
Option 2: Dilute Bleach Bath Protocol
- Concentration: 1 teaspoon bleach per gallon of water (or ¼ cup per ¼ tub/13 gallons)
- Frequency: Twice weekly
- Duration: 15 minutes per bath, continued for 3 months 1
- Important: Ensure proper dilution to avoid skin irritation; provide clear written instructions to patients
Clinical Context and Evidence Quality
The evidence supporting chlorhexidine decolonization is notably limited. The 2011 IDSA MRSA guidelines explicitly state that "there are no published data to support its efficacy in patients with recurrent MRSA SSTI" and that "the optimal regimen, frequency of application, and duration of therapy are unclear" 1. However, when used alone, chlorhexidine appears ineffective—a randomized trial found that chlorhexidine-impregnated wipes used three times weekly had no impact on skin and soft tissue infection rates 3, 1.
The combination approach is critical: Chlorhexidine works best when paired with intranasal mupirocin, not as monotherapy 1.
When to Consider Decolonization
Decolonization should be reserved for specific clinical scenarios 1:
- Recurrent SSTI: Patient develops multiple infections despite optimizing wound care and hygiene measures
- Ongoing household transmission: Close contacts continue to develop infections despite standard hygiene
- High-risk surgical patients: Particularly cardiac and orthopedic surgery patients who are MRSA or MSSA carriers 2
Important Caveats and Pitfalls
Resistance Concerns
The guidelines acknowledge that decolonization may select for more resistant or virulent strains, though this remains uncertain 1. Mupirocin resistance has been reported in some community settings 1.
Limited Efficacy Data
- A 2014 study found that scrubbing three times weekly with chlorhexidine-impregnated cloths was ineffective for preventing recurrent infections 3
- Mupirocin alone in the MRSA era did not reduce first-time SSTI incidence despite decreasing nasal colonization 1
- Recolonization occurs soon after discontinuation of chlorhexidine 1
Proper Application Technique
Per FDA labeling, for general skin cleansing with Hibiclens 4:
- Apply minimum amount necessary to cover the area
- Wash gently and rinse thoroughly
- For body decolonization: Apply after showering, focusing on high-risk areas (axilla, groin, neck)
Contraindications
Do not use chlorhexidine 4:
- In patients allergic to chlorhexidine gluconate
- On head/face as preoperative prep
- In contact with meninges or middle ear
- In genital area
- On wounds deeper than superficial skin layers
Adjunctive Hygiene Measures
Decolonization must be combined with comprehensive hygiene education 1:
- Keep draining wounds covered with clean, dry bandages
- Regular handwashing with soap and water or alcohol-based sanitizer
- Clean high-touch surfaces daily with commercial cleaners
- Avoid sharing personal items (towels, razors, clothing)
- Launder towels, sheets, and clothes daily during decolonization
Surveillance Culture Limitations
Do not routinely perform screening cultures before or after decolonization if at least one prior infection was documented as staph 1. Surveillance cultures following decolonization are not recommended in the absence of active infection.
Special Populations
For recurrent MSSA furunculosis specifically, an alternative evidence-based approach is intranasal mupirocin twice daily for the first 5 days of each month, which reduced recurrences by approximately 50% in older trials 5. However, efficacy in the current MRSA era is unclear 3.